Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Commitment to partnership and joint innovation for cell and gene therapies
Hovione announced today that it held on June 8th the official groundbreaking for the expansion of its New Jersey facility in East Windsor, USA
The Pharmaceutical Process Analytics Roundtable (PPAR) Annual Event at Hovione New Jersey
C&EN, 17 January 2022
Presented by the Hénokiens Association and the Château du Clos Lucé
Hovione is expanding its scientific know-how and industrial production capabilities on a variety of technologies to widen its ability to provide customized solutions for advanced APIs (aAPI™).
The New Jersey Department of Environmental Protection awarded Hovione New Jersey with the Environmental Stewardship
Pharmaceutical Technology, 2 Junho 2021
Hovione today announced an extension of collaboration on Zerion’s Dispersome® technology into the nutraceutical/dietary supplements field.